Drug companies gave at least $116 million to patient advocacy groups in 2015, according to a database launched Friday by Kaiser Health News. “Patient advocacy groups campaign to raise awareness of diseases, to fund research and to promote policies favorable to their causes on Capitol Hill and at the Food and Drug Administration,” KHN writes. “But do they represent patients or Big Pharma? Kaiser Health News has compiled and analyzed disclosures to shed light on the flow of money between the pharmaceutical industry and patient advocacy groups. The Pre$cription for Power database will be available for downloading in May. The database currently covers 2015 and will be updated as additional data become available.”

Related News Articles

Headline
The American Board of Medical Specialties has released an updated guide to the specialty and subspecialty certifications offered by its 24 member boards.
Headline
The AHA and the Federation of American Hospitals today urged Congress to oppose any legislation that would repeal current law limiting self-referral to…
Headline
A coalition of 40 health care and public health organizations, including the AHA, today urged the Senate to quickly pass the Pandemic and All-Hazards…
Headline
Joseph Miller, vice president of behavioral health care transformation services at Hackensack (N.J.) Meridian Health, will serve as 2019 chair of the AHA's…
Perspective
We’re 11 days into 2019 … we’ve returned to a divided government …and the partial government shutdown continues.
Headline
The House of Representatives last night passed legislation (H.R. 269) that includes the Pandemic and All-Hazards Preparedness and Advancing Innovation Act.